Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL.

Fam Cancer. 2019 Oct;18(4):389-397. doi: 10.1007/s10689-019-00136-6.

PMID:
31209717
2.

Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu C, Bien SA, Zubair N, Macinnis RJ, Buchanan DD, Hopper JL, Cao Y, Nishihara R, Rennert G, Slattery ML, Thomas DC, Woods MO, Prentice RL, Gruber SB, Zheng Y, Brenner H, Hayes RB, White E, Peters U, Hsu L; Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium.

Gastroenterology. 2018 Jun;154(8):2152-2164.e19. doi: 10.1053/j.gastro.2018.02.021. Epub 2018 Feb 17.

3.

A model to determine colorectal cancer risk using common genetic susceptibility loci.

Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, Nishihara R, Ogino S, Prentice RL, Schumacher FR, Seminara D, Slattery ML, Thomas DC, Thornquist M, Newcomb PA, Potter JD, Zheng Y, White E, Peters U; Colorectal Transdisciplinary (CORECT) Study; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO).

Gastroenterology. 2015 Jun;148(7):1330-9.e14. doi: 10.1053/j.gastro.2015.02.010. Epub 2015 Feb 13.

4.

Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer.

Qin W, Wang X, Wang Y, Li Y, Chen Q, Hu X, Wu Z, Zhao P, Li S, Zhao H, Yao W, Ding J, Wei M, Wu H.

Cancer Cell Int. 2019 Aug 20;19:215. doi: 10.1186/s12935-019-0895-x. eCollection 2019.

5.

A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.

Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D'Este C, Hill D, Barker D, Simmons J.

BMC Cancer. 2013 Jan 10;13:13. doi: 10.1186/1471-2407-13-13.

6.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review. Erratum in: Cancer. 2017 Oct 1;123(19):3857.

7.

Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.

Siebenhofer A, Plath J, Taubenroth M, Singer S, Hechtner M, Dahlhaus A, Rauck S, Schulz-Rothe S, Koné I, Gerlach FM.

BMC Cancer. 2015 Aug 28;15:605. doi: 10.1186/s12885-015-1600-7.

8.

Prediction of Colorectal Cancer Risk Using a Genetic Risk Score: The Korean Cancer Prevention Study-II (KCPS-II).

Jo J, Nam CM, Sull JW, Yun JE, Kim SY, Lee SJ, Kim YN, Park EJ, Kimm H, Jee SH.

Genomics Inform. 2012 Sep;10(3):175-83. doi: 10.5808/GI.2012.10.3.175. Epub 2012 Sep 28.

9.

Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.

Tikk K, Weigl K, Hoffmeister M, Igel S, Schwab M, Hampe J, Klug SJ, Mansmann U, Kolligs F, Brenner H.

BMC Cancer. 2018 Jul 6;18(1):720. doi: 10.1186/s12885-018-4646-5.

10.

Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Gastroenterology. 2017 Jul;153(1):307-323. doi: 10.1053/j.gastro.2017.05.013. Epub 2017 Jun 9.

PMID:
28600072
11.

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6. Review.

PMID:
28555630
12.

Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.

Dillon M, Flander L, Buchanan DD, Macrae FA, Emery JD, Winship IM, Boussioutas A, Giles GG, Hopper JL, Jenkins MA, Ait Ouakrim D.

PLoS Med. 2018 Aug 16;15(8):e1002630. doi: 10.1371/journal.pmed.1002630. eCollection 2018 Aug.

13.

Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study.

Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, Jacob I, Harvie M, Cuzick J, Brentnall A, Wilson M, Harrison F, Payne K, Howell A.

Southampton (UK): NIHR Journals Library; 2016 Aug.

14.

Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer.

Tsai MH, Xirasagar S, Li YJ, de Groen PC.

Prev Chronic Dis. 2015 May 21;12:E80. doi: 10.5888/pcd12.140533.

15.

The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese.

Abe M, Ito H, Oze I, Nomura M, Ogawa Y, Matsuo K.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2481-2492. doi: 10.1007/s00432-017-2505-4. Epub 2017 Aug 28.

PMID:
28849422
16.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

17.

Colorectal cancer-susceptibility single-nucleotide polymorphisms in Korean population.

Hong SN, Park C, Kim JI, Kim DH, Kim HC, Chang DK, Rhee PL, Kim JJ, Rhee JC, Son HJ, Kim YH.

J Gastroenterol Hepatol. 2015 May;30(5):849-57. doi: 10.1111/jgh.12331.

PMID:
23875689
19.

Colorectal cancer risk assessment and screening recommendation: a community survey of healthcare providers' practice from a patient perspective.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M.

BMC Fam Pract. 2012 Mar 14;13:17. doi: 10.1186/1471-2296-13-17.

20.

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer.

Gargallo CJ, Lanas Á, Carrera-Lasfuentes P, Ferrandez Á, Quintero E, Carrillo M, Alonso-Abreu I, García-Gonzalez MA.

Int J Cancer. 2019 Feb 1;144(3):489-502. doi: 10.1002/ijc.31858. Epub 2018 Nov 26.

Supplemental Content

Support Center